Quick Takeaways
- Brett Kaplan has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $618,450.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Brett Kaplan
- Location
- New York, NY
- Summary
- The estimated net worth of Brett Kaplan is at least $618,450 dollars as of 15 Jan 2025. Brett Kaplan is the Chief Operating Officer of Climb Bio, Inc. and owns shares of Climb Bio, Inc. (CLYM) stock worth about $618.4K.
- Signature
- /s/ Emily Pimblett, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Brett Kaplan and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Climb Bio, Inc. ($618,450).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Brett Kaplan
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CLYM | Climb Bio, Inc. | Chief Operating Officer | $618,450 | 13 Jan 2025 | ||
| CMPX | Compass Therapeutics, Inc. | Director | 18 Feb 2022 |
Insider Transactions Reported by Brett Kaplan:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.